BeiGene Provides Update on the Ociperlimab (BGB-A1217) Clinical Development Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. JPM
2. SPY
3. WFC
4. ERAS
5. IBM
6. BAC
7. TREX
8. SPRO
9. AAPL
10. GS

Go back to BeiGene Provides Update on the Ociperlimab (BGB-A1217) Clinical Development Program
Bank of Commerce (NASDAQ: ONC) Delayed: 303.96 --0 (-0%)
Previous Close $303.96    52 Week High $0.35 
Open $303.96    52 Week Low $0.35 
Day High $303.96    P/E N/A 
Day Low $303.96    EPS $0.00 
Volume 9,731